Aurobindo Pharma’s arm enters into Licence agreement with Hilleman Laboratories Singapore

28 Sep 2023 Evaluate

Aurobindo Pharma’s wholly owned subsidiary -- Auro Vaccines has entered into a Licence agreement with Hilleman Laboratories Singapore Pte. to develop, manufacture and commercialize a pentavalent vaccine candidate used in children vaccination. Auro Vaccines will make milestone payments to Hilleman upon achieving certain development and clinical study outcomes. Hilleman will also be paid royalties upon commercialization of the vaccine candidate.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1223.65 3.45 (0.28%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.